Poster Abstract Session:
53. Pediatric Antimicrobial and Diagnostic Stewardship
Thursday, October 4, 2018: 12:30 PM-1:45 PM
Room: S Poster Hall

Tracks: Epidemiology and Infection Control, Global ID, Investigative ID, Pediatric ID


Presentations:
257
A Whole of Country Analysis of Antimicrobial Stewardship Resources, Activities and Barriers for Children in Hospitals in Australia
Penelope Bryant, BM BCh, PhD; Natalie Morgan, MBBS; Vanessa Clifford, MBBS, PhD; Brendan McMullan, MBBS; Asha Bowen, MBBS FRACP
261
Alternative Antibiotic Prescribing for Community Acquired Pneumonia (CAP) in Pediatric Patients in Relation to Allergy Status
Ankita Desai, MD; Bhavana Gorti, MS; Sherman Alter, MD; Lilliam Ambroggio, PhD, MPH; Daniel Cohen, MD; Osama El-Assal, MD; Todd Florin, MD, MSCE; Meghan Keaton, MD; Asuncion Mejias, MD, PhD, MsCS; Richard Ruddy, MD; Samir Shah, MD; Rebecca Wallihan, MD; Octavio Ramilo, MD, FPIDS
262
Pediatric Antibiotic Use in the Duke Antimicrobial Stewardship Outreach Network
Michael Smith, MD, MSCE; Elizabeth Dodds Ashley, PharmD, MHS, FCCP, BCPS; Deverick J. Anderson, MD, MPH, FIDSA, FSHEA; April Dyer, PharmD, MBA, MSCR, BCPS; Travis Jones, PharmD; Melissa Johnson, PharmD, MHS; Angelina Davis, PharmD, MS, BCPS, AQ-ID; Rebekah W. Moehring, MD, MPH
Posters
  • SMITH_IDWEEK_2018.pdf (350.8 kB)
  • 263
    Effect of Microbiologic Data on Prospective Audit and Feedback Recommendations
    Laura Bio, PharmD, BCPS; Jenna Kruger, MPH; Hayden Schwenk, MD
    264
    Simple and feasible NICU antimicrobial stewardship program in a Japanese community hospital
    Taito Kitano, Medical Doctor; Kumiko Takagi, Medical Doctor; Ikuyo Arai, Medical Doctor; Hajime Yasuhara, Medical Doctor; Reiko Ebisu, Medical Doctor; Ayako Ohgitani, Medical Doctor; Daisuke Kitagawa, Microlab technician; Miyako Oka, Microlab technician; Kazue Masuo, Microlab technician; Hideki Minowa, Medical Doctor
    Posters
  • ID Week Poster.pdf (542.1 kB)
  • 265
    Identification of Solid Organ Transplant Antimicrobial Stewardship Opportunities in Pediatric Liver Transplant Patients.
    Laura Bio, PharmD, BCPS; Hayden Schwenk, MD; Sharon F. Chen, MD, MS; Hayley A. Gans, MD, FPIDS
    266
    Implementation and Evaluation of a Pharmacist-Managed Pediatric Vancomycin Protocol
    Christine Vu, PharmD; Karrine Brade, PharmD, BCPS; Camilla Farrell, PharmD, BCPS, BCPPS; Michelle Mancuso, PharmD, BCPS
    Posters
  • VuC_IDWeek.pdf (404.9 kB)
  • 268
    Cardiothoracic Surgery Antimicrobial Prophylaxis in Pediatric Patients: Reducing Antimicrobial Exposure
    Rachel L. Medernach, M.D.; Betty Vu, PharmD; Jessica Jacobson, PharmD, BCPS, BCPPS; Kristen Welsh, PharmD, BCPPS; Sara Brown, PharmD; Amy Wilhelmi, PNP; Colleen Nash, MD, MPH
    270
    Prevalence and Impact of β-Lactam Allergies at a Canadian Pediatric Center
    Jacqueline Wong, MD, FRCPC, FAAP; Mariana Torres, MD; Kathryn Timberlake, PharmD; Adelle Atkinson, MD, FRCPC; Michelle Science, MD, MSc, FRCPC
    273
    Effects of a rapid meningitis/encephalitis panel on antimicrobial use and clinical outcomes in children.
    Danielle McDonald, PharmD; Christina Gagliardo, MD; M. Cecilia Di Pentima, MD, MPH
    275
    Evaluation of Vancomycin Prescribing Quality in Hospitalized Pediatric Patients
    Francisca Abanyie-Bimbo, MD, MPH; Erin O'Leary, MPH; Joelle Nadle, MPH; Deborah L. Thompson, MD, MSPH; Daniel Muleta, MD, MPH; Marion A. Kainer, MBBS, MPH; Lauren Epstein, MD, MSc; Shelley S. Magill, MD, PhD
    276
    Vancomycin Utilization in a Neonatal Intensive Care Unit
    Kanokporn Mongkolrattanothai, MD; Leslie Stach, PharmD; Regina Orbach, PharmD; Steven Chin, MD; Srikumar Nair, MD; Hsiang-Fen Su, MD
    Posters
  • 276_IDWPOSTER.pdf (2.3 MB)
  • 277
    Assessment of a Pharmacist-Driven Voriconazole Clinical Practice Guideline in a Children’s Hospital
    Anna Huppler, MD; Anna Kissell, PharmD, BCPPS; Peter Havens, MD, MS; Tracy Zembles, PharmD, BCPS-AQ ID
    Posters
  • IDweek_277.pdf (297.9 kB)
  • 279
    A Decision Tree Using Clinical Characteristics to Predict a Hospitalized Child’s Risk of a Multidrug-Resistant Gram-Negative Bloodstream Infection
    Anna Sick-Samuels, MD, MPH; Katherine Goodman, JD; Glenn Rapsinski, MD; Elizabeth Colantuoni, PhD; Andrew Nowalk, MD, PhD; Pranita Tamma, MD, MHS
    280
    The Impact of a Revised Neutropenic Fever Guideline on Vancomycin-Resistant Enterococcus Rates in Pediatric Oncology Patients
    Manjiree Karandikar, MD, MBS; Carly Milliren, MPH; Robin Zaboulian, BS; Tanvi Sharma, MD, MPH; Andrew Place, MD, PhD; Thomas J. Sandora, MD, MPH, FSHEA
    Posters
  • Karandikar GNR Poster V2.0.pdf (364.5 kB)
  • 281
    Cefdinir prescribing increased in low-income children in Kentucky from 2012-2016
    Michael Smith, MD, MSCE; Navjyot Vidwan, MD; Bethany Wattles, PharmD; Soutik Ghosal, MS; Yana Feygin, MS; Liza Creel, PhD, MPH; John Myers, PhD, MSPH,; Charles Woods, MD, MS, FIDSA, FSHEA, FPIDS
    Posters
  • Cefdinir in Kentucky.pdf (560.5 kB)
  • 284
    Antibiotic usage in the first year of life in HIV-exposed, uninfected infants in Malawi: Results from the Breastfeeding, Antiretrovirals and Nutrition (BAN) Study
    Athena Kourtis, MD, PhD, MPH, FIDSA; Alexander Ewing, MPH; Nicole Davis, PhD; Dumbani Kayira, MBBS; Mina Hosseinipour, MD, MPH; Charles Van Der Horst, MD, FIDSA; Denise Jamieson, MD, MPH

    CME Credits: Maximum of 0.00 hours of AMA PRA Category 1 Credit™


    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.